Advertisement

Protease Inhibitors and Pancreatic Carcinogenesis

  • B. D. Roebuck
  • Daniel S. Longnecker

Abstract

In the United States, pancreatic cancer is the fifth most common cause of death due to cancer, claiming over 25,000 lives annually (Silverberg and Lubera, 1989). Males are at a slightly higher risk than females (1.5:1) and for both sexes, the age-adjusted death rates have shown a steady increase from 1930 to 1970. Usually, diagnosis of pancreatic cancer is late in the course of disease development, thus precluding effective treatment. The mean survival following diagnosis is 4 to 6 months and the 5-year survival rate is one of the worst of any cancer being less than 5% of cases (Mack, 1982).

Keywords

Pancreatic Cancer Acinar Cell Trypsin Inhibitor Syrian Golden Hamster Pancreatic Carcinogenesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adler, G., Mullenhoff, A., Bozkurt, T., Koop, I., Goke, B., Beglinger, C., and Arnold, R., 1986, Pancreatic function and plasma CCK in humans after ingestion of a proteinase inhibitor (FOY-305), Dig. Dis. Sci. 31:1123.CrossRefGoogle Scholar
  2. Andren-Sandberg, A., Dawiskiba, S., and Ihse, I., 1984, Studies of the effect of caerulein administration on experimental pancreatic carcinogenesis, Scand. J. Gastroenterol. 19:122–128.PubMedGoogle Scholar
  3. Bell, R. H., and Ray, M. B., 1987, Cytokeratin antigen in BOP-induced pancreatic tumors— Implications for histogenesis, Carcinogenesis 8:1563–1566.PubMedCrossRefGoogle Scholar
  4. Birt, D. F., Salmasi, S., and Pour, P. M., 1981, Enhancement of experimental pancreatic cancer in Syrian golden hamsters by dietary fat, J. Natl. Cancer Inst. 67:1327–1332.PubMedGoogle Scholar
  5. Booth, A. N., Robbins, D. J., Ribelin, W. E., and Deeds, F., 1960, Effects of raw soybean meal and amino acids on pancreatic hypertrophy in rats, Proc. Soc. Exp. Biol. Med. 104:681–683.Google Scholar
  6. Carroll, K. K., and Khor, H. T., 1975, Dietary fat in relation to tumorigenesis, Prog. Biochem. Pharmacol. 10:308–353.PubMedGoogle Scholar
  7. Chernick, S. S., Lepkovsky, S., and Chaikoff, I. L., 1948, A dietary factor regulating the enzyme content of the pancreas: Changes induced in size and proteolytic activity of the chick pancreas by the ingestion of raw soy-bean meal, Am. J. Physiol. 155:33–41.PubMedGoogle Scholar
  8. Crass, R. A., and Morgan, R. G. H., 1981, Rapid changes in pancreatic DNA, RNA and protein in the rat during pancreatic enlargement and involution, Int. J. Vitam. Nutr. Res. 51:85–91.PubMedGoogle Scholar
  9. Douglas, B. R., Woutersen, R. A., Jansen, J. B. M. J., de Jong, A. J. L., Rovati, L. C., and Lamers, C. B. H. W., 1989a, Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas, Cancer Res. 49:2438–2441.PubMedGoogle Scholar
  10. Douglas, B. R., Woutersen, R. A., Jansen, J. B. M. J., deJong, A. J. L., Rovati, L. C., and Lamers, C. B. H. W., 1989b, Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas, Gastroenterology 96:462–469.PubMedGoogle Scholar
  11. Durbec, J. P., Chevillotte, G., Bidart, J. M., Berthezene, P., and Sarles, H., 1983, Diet, alcohol, tobacco and risk of cancer of the pancreas: A case-control study, Br. J. Cancer 47:463–470.PubMedCrossRefGoogle Scholar
  12. Egami, T., Takai, A., Taniguchi, Y., Watanabe, A., Yano, M., Sasajima, K., Tanaka, N., Miki, M., Shirota, A., Asano, G., and Takubo, U., 1983, Effect of a protease inhibitor FOY-305 on experimental carcinoma of the pancreas induced by diisopropanol nitrosamine (DIPN), Jpn. J. Gastroenterol. 80:2023–2033.Google Scholar
  13. Flaks, B., Moore, M. A., and Flaks, A., 1982, Ultrastructural analysis of pancreatic carcinogenesis. VI. Early changes in hamster acinar cells induced by N-nitrosobis-(2-hydroxypropyl) amine, Carcinogenesis 3:1063–1070.PubMedCrossRefGoogle Scholar
  14. Folsch, U. R., Winckler, K., and Wormsley, K. G., 1974, Effect of a soybean diet on enzyme content and ultrastructure of the rat exocrine pancreas, Digestion 11:161–171.PubMedCrossRefGoogle Scholar
  15. Goke, B., Stockmann, F., Muller, R., Lankisch, P. G., and Creutzfeld, W., 1984, Effect of a specific serine protease inhibitor on the rat pancreas: Systemic administration of camostate and exocrine pancreatic secretion, Digestion 30:171–178.PubMedCrossRefGoogle Scholar
  16. Gold, E. B., Gordis, L., Diener, M. D., Seltser, R., Boitnott, J. K., Bynum, T. E., and Hutcheon, D. F., 1985, Diet and other risk factors for cancer of the pancreas, Cancer 55:460–467.PubMedCrossRefGoogle Scholar
  17. Green, G. M., and Lyman, R. L., 1972, Feedback regulation of pancreatic enzyme secretion as a mechanism for trypsin inhibitor-induced hypersecretion in rats, Proc. Soc. Exp. Biol. Med. 140:6–12PubMedGoogle Scholar
  18. Gumbmann, M. R., Spangler, W. L., Dugan, G. M., Rackis, J. J., and Liener, I. E., 1985, The USDA trypsin inhibitor study. IV. The chronic effects of soy flour and soy protein isolate on the pancreas in rats after two years, Qual. Plant Foods Hum. Nutr. 35:275–314.CrossRefGoogle Scholar
  19. Howatson, A. G., and Carter, D. C., 1985, Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model, Br. J. Cancer 51:107–114.PubMedCrossRefGoogle Scholar
  20. Johnson, F. E., LaRegina, M. C., Martin, S. A., and Bashiti, H. M., 1983, Cholecystokinin inhibits pancreatic carcinogenesis, Cancer Detect. Prevent. 6:389–402.PubMedGoogle Scholar
  21. Levison, D. A., Morgan, R. G. H., Brimacombe, J. S., Hopwood, D., Coghill, G., and Wormsley, K. G., 1979, Carcinogenic effects of di(2-hydroxypropyl)nitrosamine (DHPN) in male Wistar rats: Promotion of pancreatic cancer by raw soya flour diet, Scand. J. Gastroenterol. 14:217–224.PubMedCrossRefGoogle Scholar
  22. Lhoste, E. F., and Longnecker, D. S., 1987, Effect of bombesin and caerulein on early stages of carcinogenesis induced by azaserine in the rat pancreas, Cancer Res. 47:3273–3277.PubMedGoogle Scholar
  23. Lhoste, E. F., Roebuck, B. D., and Longnecker, D. S., 1988, Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305), Carcinogenesis 9:901–906.PubMedCrossRefGoogle Scholar
  24. Longnecker, D. S., 1987, The azaserine-induced model of pancreatic carcinogenesis in rats, in: Experimental Pancreatic Carcinogenesis (D. G. Scarpelli, J. K. Reddy, and D. S. Longnecker, eds.), CRC Press, Boca Raton, Fla., pp. 117–130.Google Scholar
  25. McGuinness, E. E., Morgan, R. G. H., Levison, D. A., Frape, D. L., Hopwood, D., and Wormsley, K. G., 1980, The effects of long-term feeding of soya flour on the rat pancreas, Scand. J. Gastroenterol. 15:497–502.PubMedCrossRefGoogle Scholar
  26. McGuinness, E. E., Morgan, R. G. H., Levison, D. A., Hopwood, D., and Wormsley, K. G., 1981, Interaction of azaserine and raw soya flour on the rat pancreas, Scand. J. Gastroenterol. 16:49–56.PubMedGoogle Scholar
  27. McGuinness, E. E., Morgan, R. G. H., and Wormsley, K. G., 1984, Effects of soybean flour on the pancreas of rats, Environ. Health Perspect. 56:205–212.PubMedCrossRefGoogle Scholar
  28. Mack, T. M., 1982, Pancreas, in: Cancer Epidemiology and Prevention (D. Schottenfeld and J. Fraumeni, eds.), Saunders, Philadelphia, pp. 638–667.Google Scholar
  29. Melmed, R. N., El-Aaser, A. A. A., and Holt, S. J., 1976, Hypertrophy and hyperplasia of the neonatal rat exocrine pancreas induced by orally administered soybean trypsin inhibitor, Biochim. Biophys. Acta 421:280–288.PubMedCrossRefGoogle Scholar
  30. Mills, P. K., Beeson, W. L., Abbey, D. E., Fraser, G. E., and Phillips, R. L., 1988, Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists, Cancer 61:2578–2585.PubMedCrossRefGoogle Scholar
  31. Miyasaka, K., Nakamura, R., Funakoshi, A., and Kitani, K., 1989, Stimulatory effect of monitor peptide and human pancreatic secretory trypsin inhibitor on pancreatic secretion and cholecystokinin release in conscious rats, Pancreas 4:139–144.PubMedCrossRefGoogle Scholar
  32. Moore, M. A., Takahashi, M., Ito, N., and Bannasch, P., 1983a, Early lesions during pancreatic carcinogenesis induced in Syrian hamsters by DHPN or DOPN. I. Histologic, histochemical, and radioautographic findings, Carcinogenesis 4:431–437.PubMedCrossRefGoogle Scholar
  33. Moore, M. A., Takahashi, M., Ito, N., and Bannasch, P., 1983b, Early lesions during pancreatic carcinogenesis induced in Syrian hamsters by DHPN or DOPN. II. Ultrastructural findings, Carcinogenesis 4:439–448.PubMedCrossRefGoogle Scholar
  34. Morgan, R. G. H., 1987, Raw soy flour and pancreatic cancer in experimental animals, in: Experimental Pancreatic Carcinogenesis (D. G. Scarpelli, J. K. Reddy, and D. S. Longnecker, eds.), CRC Press, Boca Raton, Fla., pp. 159-174.Google Scholar
  35. Morgan, R. G. H., Levison, D. A., Hopwood, D., Saunders, J. H. B., and Wormsley, K. G., 1977, Potentiation of the action of azaserine on the rat pancreas by raw soya bean flour, Cancer Lett. 3:87–90.PubMedCrossRefGoogle Scholar
  36. Norell, S. E., Ahlbom, A., Erwald, R., Jacobson, G., Lindberg-Navier, I., Olin, R., Tornberg, B., and Wiechel, K. L., 1986, Diet and pancreatic cancer: A case-control study, Am. J. Epidemiol. 124:894–902.PubMedGoogle Scholar
  37. Ohkoshi, M., and Fujii, F., 1983, Effect of the synthetic protease inhibitor N,N-dimethylcarbamoyl-methyl 4-(4-guanidinobenzoyloxy) phenylacetate methanesulfate on carcinogenesis by 3-meth-ylcholantrene in mouse skin, J. Natl. Cancer Inst. 71:1053–1057.PubMedGoogle Scholar
  38. Pour, P. M., and Lawson, T., 1984, Pancreatic carcinogenic nitrosamines in Syrian hamsters, in: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer (I. K. O’neil, R. C. von Borstel, C. T. Miller, J. Long, H. Bartsch, and C. York, eds.), International Agency for Cancer Research, Lyon, France, pp. 683–688.Google Scholar
  39. Pour, P. M., and Wilson, R., 1980, Experimental tumors of the pancreas, in: Tumors of the Pancreas (A. R. Moossa, ed.), Williams & Wilkins, Baltimore, pp. 37–158.Google Scholar
  40. Pour, P. M., Lawson, T., Helgeson, S., Donnelly, T., and Stepan, K., 1988, Effect of cholecystokinin on pancreatic carcinogenesis in the hamster model, Carcinogenesis 9:597–601.PubMedCrossRefGoogle Scholar
  41. Roebuck, B. D., 1986a, Effects of high levels of dietary fats on the growth of azaserine-induced foci in the rat pancreas, Lipids 21:281–284.PubMedCrossRefGoogle Scholar
  42. Roebuck, B. D., 1986b, Enhancement of pancreatic carcinogenesis by raw soy protein isolate: Quantitative rat model and nutritional considerations, in: Nutritional and Toxicological Significance of Enzyme Inhibitors in Foods (M. Friedman, ed.), Plenum Press, New York, pp. 91–107.CrossRefGoogle Scholar
  43. Roebuck, B. D., 1987, Enhancement of pancreatic carcinogenesis in the rat by dietary fats, in: Experimental Pancreatic Carcinogenesis (D. G. Scarpelli, J. K. Reddy, and D. S. Longnecker, eds.), CRC Press, Boca Raton, Fla., pp. 187–206.Google Scholar
  44. Roebuck, B. D., Baumgartner, K. J., and Thron, C. D., 1984, Characterization of two populations of pancreatic atypical acinar cell foci induced by azaserine in the rat, Lab. Invest. 50:141–146.PubMedGoogle Scholar
  45. Roebuck, B. D., Baumgartner, K. J., and Longnecker, D. S., 1987a, Growth of pancreatic foci and development of pancreatic cancer with a single dose of azaserine in the rat, Carcinogenesis 8:1831–1835.PubMedCrossRefGoogle Scholar
  46. Roebuck, B. D., Kaplita, P. V., Edwards, B. R., and Praissman, M., 1987b, Effects of dietary fats and soybean protein on azaserine-induced pancreatic carcinogenesis and plasma cholecystokinin in the rat, Cancer Res. 47:1333–1338.PubMedGoogle Scholar
  47. Satake, K., Mukai, R., Kato, Y., and Umeyama, K., 1986, Effects of cerulein on the normal pancreas and on experimental pancreatic carcinoma in the Syrian golden hamster, Pancreas 1:246–253.PubMedCrossRefGoogle Scholar
  48. Silverberg, E., and Lubera, J. A., 1989, Cancer statistics, Ca-A Cancer J. Clin. 39:3–20.CrossRefGoogle Scholar
  49. Struthers, B. J., MacDonald, J. R., Dahlgren, R. R., and Hopkins, D. T., 1983, Effects on the monkey, pig and rat pancreas of soy products with varying levels of trypsin inhibitor and comparison with the administration of cholecystokinin, J. Nutr. 113:86–97.PubMedGoogle Scholar
  50. Watanabe, S., Shiratori, K., Takeuchi, T., and Chey, W. Y., 1986, Intrajejunal administration of a synthetic trypsin inhibitor (camostate) stimulates the release of endogenous secretin, but not cholecystokinin in humans, Gastroenterology 90:1685.Google Scholar
  51. Wynder, E. L., 1975, An epidemiological evaluation of the causes of cancer of the pancreas, Cancer Res. 35:2228–2233.PubMedGoogle Scholar
  52. Yamamura, M., Nakamura, N., Fukui, Y., Takamura, C., Yamamoto, M., Minato, Y., Tamura, Y., and Fujii, S., 1978, Inhibition of 7,12-dimethylbenz[a]anthracene-induced mammary tumori-genesis in rats by a synthetic protease inhibitor, N,N-dimethylamino-[p-(p′-guanidinobenzoyloxy)] benzilcarbonyloxyglycolate, Gann 69:749–752.PubMedGoogle Scholar
  53. Yamauchi, Y., Kobayashi, M., and Watanabe, A., 1987, Anticarcinogenic effects of a serine protease inhibitor (FOY-305) through the suppression of neutral serine protease activity during chemical hepatocarcinogenesis in rats, Hiroshima J. Med. Sci. 36:81–87.PubMedGoogle Scholar
  54. Yokoyama, Y., Ohyama, K., and Takebe, T., 1985, Effect of a synthetic trypsin inhibitor FOY-305 on di-isopropanol nitrosamine-induced carcinoma of the pancreas in Syrian golden hamsters, Gendai Iryo 17:2331–2335.Google Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • B. D. Roebuck
    • 1
  • Daniel S. Longnecker
    • 2
  1. 1.Department of Pharmacology and Toxicology Dartmouth Medical SchoolHanoverUSA
  2. 2.Department of PathologyDartmouth Medical SchoolHanoverUSA

Personalised recommendations